free性video西欧极品,伊人依成久久人综合网,中文字幕人妻一区二区三区熟女,男女高潮激烈无遮挡免费观软件 ,成人3d动漫一区二区三区

  • FDA Approves Gilteritinib americanpharmaceuticalreview
    November 30, 2018
    On November 28, 2018, the Food and Drug Administration (FDA) approved gilteritinib (XOSPATA, Astellas Pharma) for treatment of adult patients who have relapsed or refractory.......
  • FDA grants priority review to Astellas’ NDA for gilteritinib pharmaceutical-technology
    June 01, 2018
    The US Food and Drug Administration (FDA) has accepted Astellas Pharma’s new drug application (NDA) for gilteritinib and granted priority review for the product’s use in the treatment of acute myeloid leukaemia (AML).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service